DK1044680T3 - Hidtil ukendt behandlingsmetode med et højt dosisregimen af amoxycillin og kaliumclavulanat - Google Patents

Hidtil ukendt behandlingsmetode med et højt dosisregimen af amoxycillin og kaliumclavulanat

Info

Publication number: DK1044680T3
Authority: DK; Denmark
Prior art keywords: amoxycillin; treatment; new method; high dose; dose regimen
Prior art date: 1999-04-13

Application number

DK00303033T

Other languages

English (en)

Inventor

Kevin Storm

Creighton Conley

John Roush

Original Assignee

Beecham Pharm Pte Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-13

Filing date

2000-04-11

Publication date

2003-09-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1044680(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-11 Application filed by Beecham Pharm Pte Ltd filed Critical Beecham Pharm Pte Ltd

2003-09-29 Application granted granted Critical

2003-09-29 Publication of DK1044680T3 publication Critical patent/DK1044680T3/da

Links

LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title 1
229960003022 amoxicillin Drugs 0.000 title 1
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 title 1
ABVRVIZBZKUTMK-JSYANWSFSA-M potassium clavulanate Chemical compound [K+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 ABVRVIZBZKUTMK-JSYANWSFSA-M 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Peptides Or Proteins (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

DK00303033T 1999-04-13 2000-04-11 Hidtil ukendt behandlingsmetode med et højt dosisregimen af amoxycillin og kaliumclavulanat DK1044680T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US12907499P	1999-04-13	1999-04-13
US15072799P	1999-08-25	1999-08-25
US15981399P	1999-10-15	1999-10-15

Publications (1)

Publication Number	Publication Date
DK1044680T3 true DK1044680T3 (da)	2003-09-29

Family

ID=27383840

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK200000602A DK200000602A (da)	1999-04-13	2000-04-11	Ny fremgangsåde til behandling
DK00303033T DK1044680T3 (da)	1999-04-13	2000-04-11	Hidtil ukendt behandlingsmetode med et højt dosisregimen af amoxycillin og kaliumclavulanat
DK200000133U DK200000133U3 (da)	1999-04-13	2000-04-11	Ny farmaceutisk formulering

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK200000602A DK200000602A (da)	1999-04-13	2000-04-11	Ny fremgangsåde til behandling

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK200000133U DK200000133U3 (da)	1999-04-13	2000-04-11	Ny farmaceutisk formulering

Country Status (44)

Country	Link
EP (4)	EP1044680B1 (da)
JP (2)	JP4880125B2 (da)
KR (1)	KR100634937B1 (da)
CN (1)	CN100382782C (da)
AP (1)	AP1806A (da)
AR (1)	AR031068A1 (da)
AT (2)	ATE242629T1 (da)
AU (1)	AU767177B2 (da)
BE (2)	BE1013309A5 (da)
BG (1)	BG65006B1 (da)
BR (1)	BRPI0009719B8 (da)
CA (1)	CA2366304C (da)
CO (1)	CO5170471A1 (da)
CZ (1)	CZ298801B6 (da)
DE (3)	DE10017883A1 (da)
DK (3)	DK200000602A (da)
DZ (1)	DZ3150A1 (da)
EA (1)	EA004310B1 (da)
ES (2)	ES2190692B1 (da)
FI (2)	FI4823U1 (da)
FR (1)	FR2792198A1 (da)
GB (1)	GB2351661B (da)
GR (1)	GR1003560B (da)
HU (1)	HU229097B1 (da)
IE (1)	IE20000271A1 (da)
IL (2)	IL145580A0 (da)
IT (1)	ITMI20000788A1 (da)
MA (1)	MA25352A1 (da)
MX (1)	MXPA01010377A (da)
MY (1)	MY119953A (da)
NL (2)	NL1014915C2 (da)
NO (1)	NO329694B1 (da)
NZ (1)	NZ514575A (da)
OA (1)	OA11926A (da)
PE (1)	PE20010053A1 (da)
PL (1)	PL197448B1 (da)
PT (2)	PT1044680E (da)
RO (1)	RO120817B1 (da)
SE (1)	SE0001330L (da)
SI (2)	SI1044680T1 (da)
SK (1)	SK285140B6 (da)
TR (1)	TR200102963T2 (da)
TW (1)	TWI235067B (da)
WO (1)	WO2000061116A2 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9407386D0 (en)	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
TR199800415T1 (en)	1995-09-07	1998-05-21	Smithkline Beecham Corporation	Farmas�tik form�lasyon.
SE9802973D0 (sv)	1998-09-03	1998-09-03	Astra Ab	Immediate release tablet
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en)	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en)	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6541014B2 (en)	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20030035839A1 (en) *	2001-05-15	2003-02-20	Peirce Management, Llc	Pharmaceutical composition for both intraoral and oral administration
CN1610551A (zh)	2001-07-06	2005-04-27	恩德制药公司	用作止痛剂的6－羟基羟吗啡酮的肠胃外给药
GB0117618D0 (en) *	2001-07-19	2001-09-12	Phoqus Ltd	Pharmaceutical dosage form
US6863901B2 (en)	2001-11-30	2005-03-08	Collegium Pharmaceutical, Inc.	Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en)	2001-12-05	2004-12-07	Collegium Pharmaceutical, Inc.	Compositions containing both sedative and non-sedative antihistamines
CA2480826C (fr)	2002-04-09	2012-02-07	Flamel Technologies	Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
JP2005528383A (ja) *	2002-04-10	2005-09-22	ミラー，フレッド，エイチ．	多重相・複数コンパートメントカプセルシステム
US20050042289A1 (en) *	2003-04-29	2005-02-24	Yamanouchi Pharma Technologies, Inc.	Tablets and methods for modified release of hydrophylic and other active agents
JP2007502294A (ja)	2003-08-12	2007-02-08	アドバンシスファーマスーティカルコーポレイション	抗生物質製剤、その使用法及び作成方法
EP1541129A1 (en) *	2003-12-12	2005-06-15	Cimex AG	Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid
EP1750717B1 (en) *	2004-02-11	2017-07-19	Rubicon Research Private Limited	Controlled release pharmaceutical compositions with improved bioavailability
WO2005099672A1 (en) *	2004-04-13	2005-10-27	Ranbaxy Laboratories Limited	A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
EP1880716A1 (en) *	2006-07-19	2008-01-23	Sandoz AG	Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
WO2008045060A1 (en) *	2006-10-10	2008-04-17	Penwest Pharmaceuticals Co.	Robust sustained release formulations
TR200909787A2 (tr)	2009-12-25	2011-07-21	Bi̇lgi̇ç Mahmut	Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000687A1 (tr)	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
WO2016164470A1 (en)	2015-04-07	2016-10-13	Church & Dwight Co., Inc.	Multicomponent gummy compositions with soft core
CN109394718B (zh) *	2018-11-15	2021-04-27	石药集团中诺药业（石家庄）有限公司	一种阿莫西林分散片及其制备方法
CN110051637A (zh) *	2019-05-21	2019-07-26	葵花药业集团北京药物研究院有限公司	阿莫西林克拉维酸钾制剂及其制备方法
WO2023208241A1 (zh) *	2022-04-29	2023-11-02	越洋医药开发(广州)有限公司	一种吡非尼酮持续性释放口服固体制剂

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0008905B1 (en) *	1978-09-06	1983-02-16	Beecham Group Plc	Pharmaceutical compositions containing two beta-lactam derivatives
IL58461A0 (en) *	1978-10-27	1980-01-31	Beecham Group Ltd	Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) *	1979-12-07	1981-06-12	Panoz Donald	Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) *	1990-04-07	1990-06-06	Beecham Group Plc	Pharmaceutical formulation
GB9109862D0 (en) *	1991-05-08	1991-07-03	Beecham Lab Sa	Pharmaceutical formulations
IT1255522B (it) *	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
EP1034784A3 (en) *	1993-01-22	2001-06-27	Smithkline Beecham Plc	Pharmaceutical formulations containing clavulanic acid and an antibacterial agent
GB9311030D0 (en) *	1993-05-28	1993-07-14	Smithkline Beecham Corp	Pharmaceutical formulations
IL109770A0 (en) *	1993-05-29	1994-11-28	Smithkline Beecham Corp	Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
GB9407386D0 (en) *	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
ITMI941169A1 (it) *	1994-06-06	1995-12-06	Smithkline Beecham Farma	Formulazioni farmaceutiche
GB9416600D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
GB9416599D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
TR199800415T1 (en) *	1995-09-07	1998-05-21	Smithkline Beecham Corporation	Farmas�tik form�lasyon.
GB9616536D0 (en) *	1996-08-06	1996-09-25	Quadrant Holdings Cambridge	Co-amoxiclav dosage form
CA2280857A1 (en) *	1997-02-14	1998-08-20	Smithkline Beecham Laboratoires Pharmaceutiques	Pharmaceutical formulations comprising amoxocyllin and clavulanate
EE9900396A (et) *	1997-03-11	2000-04-17	Almag Al	Meetod ning seade metallide katmiseks
SE9700885D0 (sv) *	1997-03-12	1997-03-12	Astra Ab	New pharmaceutical formulation
ID22340A (id) *	1997-03-25	1999-09-30	Takeda Chemical Industries Ltd	Komposisi farmasi lekat-mukosa saluran pencernaan
JP3746901B2 (ja) *	1997-10-15	2006-02-22	ユニ・チャーム株式会社	開閉自在容器
GB9815532D0 (en) *	1998-07-17	1998-09-16	Lek Pharmaceutical & Cvhemical	Pharmaceutical suspension formulation
GB9818927D0 (en) *	1998-08-28	1998-10-21	Smithkline Beecham Plc	Pharmaceutical formulation
US6225304B1 (en) *	1999-02-17	2001-05-01	Pharmaceutical Solutions, Inc.	Soluble forms of amoxicillin and treatment of animals

2000
- 2000-04-11 NO NO20001870A patent/NO329694B1/no not_active IP Right Cessation
- 2000-04-11 EP EP00303033A patent/EP1044680B1/en not_active Expired - Lifetime
- 2000-04-11 EP EP02078926A patent/EP1269996A1/en not_active Withdrawn
- 2000-04-11 PT PT00303033T patent/PT1044680E/pt unknown
- 2000-04-11 AT AT00303033T patent/ATE242629T1/de active
- 2000-04-11 AT AT0027900U patent/AT4327U1/de not_active IP Right Cessation
- 2000-04-11 BE BE2000/0255A patent/BE1013309A5/fr not_active IP Right Cessation
- 2000-04-11 FI FI20000164U patent/FI4823U1/fi active
- 2000-04-11 CZ CZ20001311A patent/CZ298801B6/cs not_active IP Right Cessation
- 2000-04-11 CN CNB008086737A patent/CN100382782C/zh not_active Expired - Lifetime
- 2000-04-11 AP APAP/P/2001/002284A patent/AP1806A/en active
- 2000-04-11 DK DK200000602A patent/DK200000602A/da not_active Application Discontinuation
- 2000-04-11 IT IT2000MI000788A patent/ITMI20000788A1/it unknown
- 2000-04-11 IE IE20000271A patent/IE20000271A1/en not_active IP Right Cessation
- 2000-04-11 TW TW089106937A patent/TWI235067B/zh not_active IP Right Cessation
- 2000-04-11 ES ES200000935A patent/ES2190692B1/es not_active Withdrawn - After Issue
- 2000-04-11 CO CO00026419A patent/CO5170471A1/es not_active Application Discontinuation
- 2000-04-11 NL NL1014915A patent/NL1014915C2/nl not_active IP Right Cessation
- 2000-04-11 DK DK00303033T patent/DK1044680T3/da active
- 2000-04-11 EA EA200101075A patent/EA004310B1/ru not_active IP Right Cessation
- 2000-04-11 SE SE0001330A patent/SE0001330L/xx not_active Application Discontinuation
- 2000-04-11 OA OA1200100257A patent/OA11926A/en unknown
- 2000-04-11 ES ES00303033T patent/ES2202004T3/es not_active Expired - Lifetime
- 2000-04-11 MX MXPA01010377A patent/MXPA01010377A/es active IP Right Grant
- 2000-04-11 CA CA002366304A patent/CA2366304C/en not_active Expired - Lifetime
- 2000-04-11 SI SI200030183T patent/SI1044680T1/xx unknown
- 2000-04-11 FI FI20000863A patent/FI20000863A7/fi unknown
- 2000-04-11 HU HU0001471A patent/HU229097B1/hu unknown
- 2000-04-11 PT PT102450A patent/PT102450B/pt active IP Right Grant
- 2000-04-11 AR ARP000101657A patent/AR031068A1/es not_active Application Discontinuation
- 2000-04-11 SI SI200000097A patent/SI20304A/sl not_active IP Right Cessation
- 2000-04-11 BR BRPI0009719A patent/BRPI0009719B8/pt not_active IP Right Cessation
- 2000-04-11 NL NL1014914A patent/NL1014914C1/nl not_active IP Right Cessation
- 2000-04-11 MY MYPI20001509A patent/MY119953A/en unknown
- 2000-04-11 GB GB0008923A patent/GB2351661B/en not_active Revoked
- 2000-04-11 RO ROA200000399A patent/RO120817B1/ro unknown
- 2000-04-11 SK SK534-2000A patent/SK285140B6/sk not_active IP Right Cessation
- 2000-04-11 FR FR0004631A patent/FR2792198A1/fr active Pending
- 2000-04-11 DE DE10017883A patent/DE10017883A1/de not_active Withdrawn
- 2000-04-11 EP EP02078928A patent/EP1269997A1/en not_active Withdrawn
- 2000-04-11 DE DE60003255T patent/DE60003255T2/de not_active Expired - Lifetime
- 2000-04-11 EP EP02078927A patent/EP1270005A3/en not_active Withdrawn
- 2000-04-11 DZ DZ003150A patent/DZ3150A1/xx active
- 2000-04-11 BE BE00/0256A patent/BE1012733A6/fr not_active IP Right Cessation
- 2000-04-11 DK DK200000133U patent/DK200000133U3/da not_active IP Right Cessation
- 2000-04-11 DE DE20006626U patent/DE20006626U1/de not_active Expired - Lifetime
- 2000-04-11 JP JP2000610449A patent/JP4880125B2/ja not_active Expired - Lifetime
- 2000-04-11 BG BG104329A patent/BG65006B1/bg unknown
- 2000-04-11 NZ NZ514575A patent/NZ514575A/en not_active IP Right Cessation
- 2000-04-11 IL IL14558000A patent/IL145580A0/xx active IP Right Grant
- 2000-04-11 PL PL339591A patent/PL197448B1/pl unknown
- 2000-04-11 WO PCT/IB2000/000992 patent/WO2000061116A2/en not_active Ceased
- 2000-04-11 PE PE2000000332A patent/PE20010053A1/es not_active Application Discontinuation
- 2000-04-11 GR GR20000100122A patent/GR1003560B/el unknown
- 2000-04-11 KR KR1020017012988A patent/KR100634937B1/ko not_active Expired - Fee Related
- 2000-04-11 AU AU57020/00A patent/AU767177B2/en not_active Expired
- 2000-04-11 TR TR2001/02963T patent/TR200102963T2/xx unknown
2001
- 2001-09-24 IL IL145580A patent/IL145580A/en not_active IP Right Cessation
- 2001-10-12 MA MA26356A patent/MA25352A1/fr unknown
2011
- 2011-07-22 JP JP2011161132A patent/JP2011256180A/ja active Pending

Also Published As

Publication number	Publication date
AU767177B2 (en)	2003-11-06
CN1382040A (zh)	2002-11-27
GR1003560B (el)	2001-03-16
IL145580A0 (en)	2002-11-10
AP2001002284A0 (en)	2001-12-31
CO5170471A1 (es)	2002-06-27
NL1014915C2 (nl)	2001-02-12
GB2351661A (en)	2001-01-10
DK200000133U3 (da)	2000-07-28
DE60003255D1 (de)	2003-07-17
PT102450A (pt)	2001-02-01
WO2000061116A3 (en)	2001-02-01
SE0001330L (sv)	2000-10-14
PL197448B1 (pl)	2008-03-31
SK285140B6 (sk)	2006-07-07
NO20001870L (no)	2000-10-16
CZ20001311A3 (cs)	2000-11-15
IL145580A (en)	2007-05-15
PL339591A1 (en)	2000-10-23
WO2000061116A2 (en)	2000-10-19
CN100382782C (zh)	2008-04-23
DZ3150A1 (fr)	2000-10-19
EP1270005A3 (en)	2006-05-17
ES2190692B1 (es)	2004-11-16
GB2351661B (en)	2001-10-10
EA200101075A1 (ru)	2002-04-25
MY119953A (en)	2005-08-30
KR20020015312A (ko)	2002-02-27
BE1013309A5 (fr)	2001-11-06
ITMI20000788A1 (it)	2001-10-11
FI20000863A0 (fi)	2000-04-11
DE20006626U1 (de)	2000-10-19
MA25352A1 (fr)	2001-12-31
KR100634937B1 (ko)	2006-10-17
FIU20000164U0 (fi)	2000-04-11
HK1032741A1 (en)	2001-08-03
FI20000863L (fi)	2000-10-13
CA2366304A1 (en)	2000-10-19
TR200102963T2 (tr)	2002-02-21
NO329694B1 (no)	2010-12-06
EA004310B1 (ru)	2004-02-26
EP1269997A1 (en)	2003-01-02
HU229097B1 (en)	2013-07-29
ATE242629T1 (de)	2003-06-15
HU0001471D0 (en)	2000-06-28
FI20000863A7 (fi)	2000-10-13
GB0008923D0 (en)	2000-05-31
BG104329A (en)	2001-11-30
OA11926A (en)	2006-04-12
AU5702000A (en)	2000-11-14
BG65006B1 (bg)	2006-12-29
IE20000271A1 (en)	2001-04-04
HUP0001471A3 (en)	2001-10-29
JP4880125B2 (ja)	2012-02-22
PT1044680E (pt)	2003-10-31
HUP0001471A2 (en)	2001-03-28
SE0001330D0 (sv)	2000-04-11
NZ514575A (en)	2004-05-28
AP1806A (en)	2007-12-14
DE10017883A1 (de)	2000-10-26
SI20304A (sl)	2001-02-28
JP2002541187A (ja)	2002-12-03
AT4327U1 (de)	2001-06-25
PT102450B (pt)	2003-09-30
PE20010053A1 (es)	2001-03-10
ES2202004T3 (es)	2004-04-01
BR0009719B1 (pt)	2014-09-30
JP2011256180A (ja)	2011-12-22
CZ298801B6 (cs)	2008-02-06
SI1044680T1 (en)	2003-12-31
CA2366304C (en)	2004-06-29
FR2792198A1 (fr)	2000-10-20
BR0009719A (pt)	2002-01-08
NL1014914C1 (nl)	2000-10-16
ES2190692A1 (es)	2003-08-01
RO120817B1 (ro)	2006-08-30
BRPI0009719B8 (pt)	2021-05-25
ITMI20000788A0 (it)	2000-04-11
BE1012733A6 (fr)	2001-02-06
DK200000602A (da)	2000-10-14
EP1269996A1 (en)	2003-01-02
DE60003255T2 (de)	2004-05-06
NO20001870D0 (no)	2000-04-11
MXPA01010377A (es)	2002-10-23
FI4823U1 (fi)	2001-02-16
AR031068A1 (es)	2003-09-10
EP1044680A1 (en)	2000-10-18
TWI235067B (en)	2005-07-01
EP1044680B1 (en)	2003-06-11
EP1270005A2 (en)	2003-01-02
SK5342000A3 (en)	2000-11-07
NL1014915A1 (nl)	2000-10-16

Publication	Publication Date	Title
DK1044680T3 (da)	2003-09-29	Hidtil ukendt behandlingsmetode med et højt dosisregimen af amoxycillin og kaliumclavulanat
LU92517I2 (fr)	2014-10-13	Delamanide et ses dérivés pharmaceutiquement acceptables
LU92513I2 (fr)	2015-11-02	Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi)
NO993887L (no)	1999-08-12	Farmasöytiske formuleringer som innbefatter amoksycillin og clavulanat
LU92024I2 (fr)	2012-08-20	Pasireotide et ses dérivés pharmaceutiquement acceptables (SIGNIFOR)
LU92745I2 (fr)	2015-08-17	Nétupitant/Palonosétron et leurs dérivés pharmaceutiquement acceptables (AKYNZEOr)
LU92419I2 (fr)	2014-06-02	Riociguat et ses dérivés pharmaceutiquement acceptables (ADEMPAS®)
NO20014504D0 (no)	2001-09-17	Anordning og fremgangsmåte for rehabilitering av tinnitus
NO932127L (no)	1993-12-13	Imidatderivater og farmasoeytisk nyttige sulfamater med antikonvulserende virkning
LU92336I2 (fr)	2014-02-17	Trastuzumab emtansine et ses dérivés pharmaceutiquement acceptables (KADCYLA)
DK0810884T3 (da)	2006-08-28	Behandling af vaskulær trombose og restenose med inhaleret nitrogenoxid
NO20023369D0 (no)	2002-07-12	Tannbleking og imageforbedring sentermetode
EP1540716A4 (en)	2008-12-24	DUPLICATION AND TRANSFER OF MICROSTRUCTURES AND NANOSTRUCTURES
DK0996444T3 (da)	2007-07-02	Behandling af diabetes med thiazolidindion og metformin
DK0862431T3 (da)	2002-03-11	Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
NO20023342L (no)	2002-09-05	Fremgangsmåte for fjernelse av NOX og N2O
NO20030668D0 (no)	2003-02-10	Apparat og metode for telemetri
LU91882I2 (fr)	2013-04-12	Pradofloxacin et ses dérivés pharmaceutiquement acceptables (VERAFLOX®)
LU91883I2 (fr)	2013-04-12	Pradofloxacin et ses dérivés pharmaceutiquement acceptables (VERAFLOX®)
GB2346573B (en)	2001-01-10	Drill jig and method of treatment of timber
NO994165D0 (no)	1999-08-27	Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
LU92634I2 (fr)	2015-11-02	Flutémétamol (18f) et ses dérivés pharmaceutiquement acceptables (vizamyl)
DK141793D0 (da)	1993-12-21	Maskine med indretninger til formindskelse af forplantning af strukturbaaren lyd
NO996265L (no)	1999-12-17	Behandling av diabetes med rosiglitazon og insulin
NO995950L (no)	2000-01-19	Fremgangsmåte og apparat for ladning av borehull med eksplosiver